Certified by Founder Lodge
NanoPhoria
Italy - Milan, Lombardy
START UP
1 Disclosed Funding Rounds $97,716,710
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
NanoPhoria is a preclinical stage biotech company pioneering inhalable cardiovascular treatments via non-viral nano-delivery of biologics.
The Company is devoted to the clinical developmen
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 07 ,2025 | Series A | $97,716,710 |
Panakes Partners
XGEN Venture
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
